guanabenz has been researched along with Inflammation in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bertozzi, F; Gardell, LR; Gaubert, G; Kelly, NM; Lameh, J; Nash, NR; Olsson, R; Pawlas, J; Scully, AL | 1 |
| Edwards, BS; Graves, SW; Saunders, MJ; Sklar, LA; Zhu, J | 1 |
| Thompson, KK; Tsirka, SE | 1 |
| Li, T; Luo, X; She, X; Sun, X; Wang, F; Yan, Q; Yang, S; Zhang, P; Zhu, H | 1 |
| Brugarolas, P; Clayton, BL; Collins, TL; Kunjamma, RB; Miller, RH; Miller, SD; Podojil, JR; Popko, B; Robinson, AP; Way, SW; Zaremba, A | 1 |
| Chen, A; Hamamura, K; Li, BY; Liu, S; Nishimura, A; Sudo, A; Takigawa, S; Yokota, H | 1 |
6 other study(ies) available for guanabenz and Inflammation
| Article | Year |
|---|---|
Discovery of selective nonpeptidergic neuropeptide FF2 receptor agonists.
Topics: Analgesics; Animals; Carrageenan; Guanidines; Humans; In Vitro Techniques; Inflammation; Microsomes, Liver; Pain; Pain Measurement; Peripheral Nervous System Diseases; Rats; Receptors, Neuropeptide | 2009 |
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; High-Throughput Screening Assays; Humans; Inflammation; Kinetics; Microspheres; Peptide Hydrolases; Peptides; Reproducibility of Results; Temperature | 2010 |
Guanabenz modulates microglia and macrophages during demyelination.
Topics: Animals; Antihypertensive Agents; B7-2 Antigen; Central Nervous System; Demyelinating Diseases; Encephalomyelitis, Autoimmune, Experimental; Female; Guanabenz; Inflammation; Macrophage Activation; Macrophages; Mice; Mice, Inbred C57BL; Microglia; Multiple Sclerosis; Neurons; Nitric Oxide Synthase Type II; Oligodendroglia; Patient Safety; Phagocytosis; Remyelination | 2020 |
Modulation of α-adrenoceptor signalling protects photoreceptors after retinal detachment by inhibiting oxidative stress and inflammation.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-2 Receptor Agonists; Animals; Apoptosis; Disease Models, Animal; Doxazosin; Guanabenz; Hyaluronic Acid; Inflammation; Injections, Intraperitoneal; Male; Oxidative Stress; Photoreceptor Cells; Protective Agents; Rats; Rats, Inbred BN; Receptors, Adrenergic, alpha-1; Signal Transduction | 2019 |
Pharmaceutical integrated stress response enhancement protects oligodendrocytes and provides a potential multiple sclerosis therapeutic.
Topics: Animals; CD4-Positive T-Lymphocytes; Cell Differentiation; Cell Survival; Cells, Cultured; Central Nervous System; Cerebellum; Cytokines; Disease Models, Animal; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Female; Guanabenz; Inflammation; Interferon-gamma; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Myelin Sheath; Oligodendroglia; Rats; Rats, Sprague-Dawley; Stem Cells | 2015 |
Guanabenz Downregulates Inflammatory Responses via eIF2α Dependent and Independent Signaling.
Topics: Animals; Anti-Inflammatory Agents; Bone Marrow Cells; Cells, Cultured; Cyclooxygenase 2; Down-Regulation; Eukaryotic Initiation Factor-2; Granulocyte-Macrophage Colony-Stimulating Factor; Guanabenz; Humans; Inflammation; Interleukin-6; Jurkat Cells; Macrophages; Mast Cells; Mice; Signal Transduction; Transcriptome; Tumor Necrosis Factor-alpha | 2016 |